Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
about
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
description
scientific article published on 27 April 2020
@en
name
Safety and feasibility of CRIS ...... ory non-small-cell lung cancer
@en
type
label
Safety and feasibility of CRIS ...... ory non-small-cell lung cancer
@en
prefLabel
Safety and feasibility of CRIS ...... ory non-small-cell lung cancer
@en
P2093
P1433
P1476
Safety and feasibility of CRIS ...... ory non-small-cell lung cancer
@en
P2093
Bingwen Zou
Binwu Ying
Chong Chen
Haige Shen
Jianxin Xue
P356
10.1038/S41591-020-0840-5
P50
P577
2020-04-27T00:00:00Z